Life sciences firm Revvity (NYSE:RVTY) reported fourth-quarter revenue and profit that topped Wall Street forecasts, though analysts remain watchful of the company's ability to sustain momentum beyond recent quarters.
A new report reveals a strategic pivot in recruitment for 2026, emphasizing targeted hiring amidst operational challenges and major workforce reductions at companies like Amazon.
An analysis of President Trump's recent op-ed claims reveals significant discrepancies between his portrayal of tariff success and official trade figures, price impact studies, and the nuanced reality of their implementation.
Tether, the company behind the world's dominant stablecoin, has quietly built a balance sheet rivaling major financial institutions, amassing vast holdings of U.S. Treasury debt and gold. Its explosive growth is reshaping its role in traditional finance and drawing regulatory scrutiny.
A new report from crypto market maker Wintermute Ventures forecasts a seismic shift, arguing that blockchain-based prediction markets will begin displacing traditional insurance by making hyper-specific risks tradable. The firm outlines a future where decentralized infrastructure becomes the new clearing layer for a programmable global economy.
Prominent crypto analyst Tom Lee faces a wave of skepticism after his aggressive price predictions for Ethereum and Bitcoin fail to materialize amid a market downturn, sparking debate over the role of high-profile forecasts in volatile markets.
Wells Fargo's board has approved a 28% compensation increase for CEO Charlie Scharf, bringing his total package to $40 million for the past year. The move comes as the bank marks a pivotal turnaround, with major federal penalties lifted and its transformation under Scharf's leadership cited as justification for the raise.
Tyson Foods reported a 6.2% increase in Q1 2026 sales to $14.3 billion, driven by robust demand for protein. While the Chicken and Prepared Foods segments showed strength, the company is restructuring its Beef operations, closing one plant and scaling back another, to align with a constrained cattle supply outlook.
Despite posting strong quarterly results and outperforming major indices over the past year, U.S. Bancorp's stock is met with a measured 'Moderate Buy' consensus from analysts, highlighting a divergence between performance and sentiment.
SoFi Technologies' record loan originations in Q4 2026 are just the beginning. With a foothold in personal, student, and home loans, the fintech giant is poised to capture a massive share of multi-trillion-dollar markets, driven by refinancing demand and cross-selling to its growing member base.
Aptiv reported record fourth-quarter revenue of $5.2 billion, a 3% increase, as the automotive technology leader prepares to spin off its Electrical Distribution Systems business as the independent company Versagen on April 1, 2026.
Shares of Coastal Financial (CCB) have retreated sharply from recent highs, reigniting the debate over the fintech-focused bank's premium valuation. While long-term performance remains strong, current momentum is fading, leaving investors to weigh high growth expectations against traditional valuation metrics.
Goldman Sachs raises Sweetgreen's price target to $5.60, citing policy tailwinds for consumer spending, even as it maintains a Sell rating. The salad chain's expansion and strong revenue growth continue to draw investor attention.
JPMorgan raises its price target for Celsius Holdings (CELH) to $77, citing upside potential from its deepening PepsiCo partnership and the expanding distribution of its Alani Nu brand ahead of Q4 earnings.
Aptiv PLC sees mixed but upwardly revised price targets from major analysts, with Piper Sandler upgrading the auto tech supplier to Overweight and naming it a top pick for 2026, citing its pragmatic strategy and attractive valuation.
Wall Street's top analysts made waves Monday with revised ratings on key stocks, highlighting a growing divergence in tech and retail outlooks as earnings season approaches.
Russia's premier cryptocurrency miner, BitRiver, faces insolvency proceedings as its CEO is placed under house arrest, marking a dramatic fall for a firm already crippled by international sanctions and mounting legal disputes.
While Legend Biotech's CAR-T therapy Carvykti missed Q4 sales estimates, prompting mixed analyst reactions, some firms emphasize its curative potential and view the stock's recent decline as a strategic entry point for investors.
Ardelyx, Inc. (NASDAQ: ARDX) has received significant analyst upgrades, with TD Cowen and Jefferies raising price targets ahead of the company's fourth-quarter results. The optimism centers on the commercial trajectory of its flagship drug, tenapanor, for gastrointestinal and kidney conditions.
The famed Pennsylvania groundhog saw his shadow on Gobbler's Knob, forecasting a prolonged winter season as thousands braved the cold for the iconic ceremony, while meteorologists warn of ongoing cold spells across the eastern U.S.
